These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35878723)

  • 1. Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis.
    Reeves JA; Bergsland N; Dwyer MG; Wilding GE; Jakimovski D; Salman F; Sule B; Meineke N; Weinstock-Guttman B; Zivadinov R; Schweser F
    Neuroimage; 2022 Nov; 261():119503. PubMed ID: 35878723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis.
    Voon CC; Wiltgen T; Wiestler B; Schlaeger S; Mühlau M
    Neuroimage Clin; 2024; 42():103598. PubMed ID: 38582068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
    Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
    Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing brain iron in multiple sclerosis: The difference between concentration and content in iron MRI.
    Schweser F; Hagemeier J; Dwyer MG; Bergsland N; Hametner S; Weinstock-Guttman B; Zivadinov R
    Hum Brain Mapp; 2021 Apr; 42(5):1463-1474. PubMed ID: 33378095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of deep gray matter magnetic susceptibility over 2 years in multiple sclerosis and healthy control brain.
    Hagemeier J; Zivadinov R; Dwyer MG; Polak P; Bergsland N; Weinstock-Guttman B; Zalis J; Deistung A; Reichenbach JR; Schweser F
    Neuroimage Clin; 2018; 18():1007-1016. PubMed ID: 29868452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated segmentation of cerebral deep gray matter from MRI scans: effect of field strength on sensitivity and reliability.
    Chu R; Hurwitz S; Tauhid S; Bakshi R
    BMC Neurol; 2017 Sep; 17(1):172. PubMed ID: 28874119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron-related gene variants and brain iron in multiple sclerosis and healthy individuals.
    Hagemeier J; Ramanathan M; Schweser F; Dwyer MG; Lin F; Bergsland N; Weinstock-Guttman B; Zivadinov R
    Neuroimage Clin; 2018; 17():530-540. PubMed ID: 29201641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of mesoscopic properties of deep gray matter iron through a model-based simultaneous analysis of magnetic susceptibility and R
    Taege Y; Hagemeier J; Bergsland N; Dwyer MG; Weinstock-Guttman B; Zivadinov R; Schweser F
    Neuroimage; 2019 Feb; 186():308-320. PubMed ID: 30445148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging detection of deep gray matter iron deposition in multiple sclerosis: A systematic review.
    De Lury AD; Bisulca JA; Lee JS; Altaf MD; Coyle PK; Duong TQ
    J Neurol Sci; 2023 Oct; 453():120816. PubMed ID: 37827008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF Markers of Oxidative Stress Are Associated with Brain Atrophy and Iron Accumulation in a 2-Year Longitudinal Cohort of Early MS.
    Burgetova A; Dusek P; Uher T; Vaneckova M; Vejrazka M; Burgetova R; Horakova D; Srpova B; Kalousova M; Noskova L; Levova K; Krasensky J; Lambert L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter.
    Elkady AM; Cobzas D; Sun H; Blevins G; Wilman AH
    J Magn Reson Imaging; 2017 Nov; 46(5):1464-1473. PubMed ID: 28301067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mean R2* in the deep gray matter of multiple sclerosis patients: Have we been measuring atrophy?
    Hernández-Torres E; Wiggermann V; Machan L; Sadovnick AD; Li DKB; Traboulsee A; Hametner S; Rauscher A
    J Magn Reson Imaging; 2019 Jul; 50(1):201-208. PubMed ID: 30511803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five year iron changes in relapsing-remitting multiple sclerosis deep gray matter compared to healthy controls.
    Elkady AM; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
    Mult Scler Relat Disord; 2019 Aug; 33():107-115. PubMed ID: 31181540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Implications of Deep Gray Matter Iron in Multiple Sclerosis.
    Fujiwara E; Kmech JA; Cobzas D; Sun H; Seres P; Blevins G; Wilman AH
    AJNR Am J Neuroradiol; 2017 May; 38(5):942-948. PubMed ID: 28232497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
    Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
    Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential changes in deep and cortical gray matters of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.
    Zhou F; Zee CS; Gong H; Shiroishi M; Li J
    J Comput Assist Tomogr; 2010; 34(3):431-6. PubMed ID: 20498549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes of deep gray matter shape in multiple sclerosis.
    Tsagkas C; Geiter E; Gaetano L; Naegelin Y; Amann M; Parmar K; Papadopoulou A; Wuerfel J; Kappos L; Sprenger T; Granziera C; Mallar Chakravarty M; Magon S
    Neuroimage Clin; 2022; 35():103137. PubMed ID: 36002960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.
    Pudlac A; Burgetova A; Dusek P; Nytrova P; Vaneckova M; Horakova D; Krasensky J; Lambert L
    Biomed Res Int; 2020; 2020():6492786. PubMed ID: 32509866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sub-voxel quantitative susceptibility mapping for assessing whole-brain magnetic susceptibility from ages 4 to 80.
    Lao G; Liu Q; Li Z; Guan X; Xu X; Zhang Y; Wei H
    Hum Brain Mapp; 2023 Dec; 44(17):5953-5971. PubMed ID: 37721369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.